348 related articles for article (PubMed ID: 34638371)
1. Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias.
Duchmann M; Laplane L; Itzykson R
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638371
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic Mechanisms in Acute Myeloid Leukemia.
Chakraborty S; Park CY
Curr Treat Options Oncol; 2022 Nov; 23(11):1522-1534. PubMed ID: 36190670
[TBL] [Abstract][Full Text] [Related]
3. Emergence of heterogeneity in acute leukemias.
Stiehl T; Lutz C; Marciniak-Czochra A
Biol Direct; 2016 Oct; 11(1):51. PubMed ID: 27733173
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the Genetic and Non-Genetic Heterogeneity of Acute Myeloid Leukemia Using Next-Generation Sequencing and In Vivo Models.
Desai RH; Zandvakili N; Bohlander SK
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565315
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Sequencing: Ariadne's Thread in the Maze of Acute Myeloid Leukemia.
Redavid I; Conserva MR; Anelli L; Zagaria A; Specchia G; Musto P; Albano F
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454044
[TBL] [Abstract][Full Text] [Related]
6. Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia.
Itzykson R; Duployez N; Fasan A; Decool G; Marceau-Renaut A; Meggendorfer M; Jourdan E; Petit A; Lapillonne H; Micol JB; Cornillet-Lefebvre P; Ifrah N; Leverger G; Dombret H; Boissel N; Haferlach T; Preudhomme C
Blood; 2018 Jul; 132(2):187-196. PubMed ID: 29692343
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic pathways in acute myeloid leukemias.
Cucuianu A
Rom J Physiol; 2004; 41(1-2):109-18. PubMed ID: 15984661
[TBL] [Abstract][Full Text] [Related]
8. Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia.
Woll PS; Yoshizato T; Hellström-Lindberg E; Fioretos T; Ebert BL; Jacobsen SEW
J Intern Med; 2022 Aug; 292(2):262-277. PubMed ID: 35822488
[TBL] [Abstract][Full Text] [Related]
9. [Application and clinical study of clonal heterogeneity analysis in acute myeloid leukemia].
Lyu XD; Guo Z; Li YW; Hu JY; Fan RH; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):483-489. PubMed ID: 32654462
[No Abstract] [Full Text] [Related]
10. Dominant and opportunistic leukemic clones: proposal for a pathogenesis-oriented classification in acute myeloid leukemia.
Cucuianu A
Med Hypotheses; 2005; 65(1):107-13. PubMed ID: 15893127
[TBL] [Abstract][Full Text] [Related]
11. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.
Chao MP; Gentles AJ; Chatterjee S; Lan F; Reinisch A; Corces MR; Xavy S; Shen J; Haag D; Chanda S; Sinha R; Morganti RM; Nishimura T; Ameen M; Wu H; Wernig M; Wu JC; Majeti R
Cell Stem Cell; 2017 Mar; 20(3):329-344.e7. PubMed ID: 28089908
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.
Carr RM; Patnaik MM
Curr Opin Hematol; 2020 Jan; 27(1):2-10. PubMed ID: 31688455
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
[TBL] [Abstract][Full Text] [Related]
14. Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm.
Sato S; Itonaga H; Taguchi M; Sawayama Y; Imanishi D; Tsushima H; Hata T; Moriuchi Y; Mishima H; Kinoshita A; Yoshiura KI; Miyazaki Y
Int J Hematol; 2018 Aug; 108(2):213-217. PubMed ID: 29417354
[TBL] [Abstract][Full Text] [Related]
15. Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia.
Paguirigan AL; Smith J; Meshinchi S; Carroll M; Maley C; Radich JP
Sci Transl Med; 2015 Apr; 7(281):281re2. PubMed ID: 25834112
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity and clonal evolution in acute myeloid leukemia.
Romer-Seibert JS; Meyer SE
Curr Opin Hematol; 2021 Jan; 28(1):64-70. PubMed ID: 33186150
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia.
Kotini AG; Carcamo S; Cruz-Rodriguez N; Olszewska M; Wang T; Demircioglu D; Chang CJ; Bernard E; Chao MP; Majeti R; Luo H; Kharas MG; Hasson D; Papapetrou EP
Blood Cancer Discov; 2023 Jul; 4(4):318-335. PubMed ID: 37067914
[TBL] [Abstract][Full Text] [Related]
18. An evolutionary perspective on chronic myelomonocytic leukemia.
Itzykson R; Solary E
Leukemia; 2013 Jul; 27(7):1441-50. PubMed ID: 23558522
[TBL] [Abstract][Full Text] [Related]
19. Clonal evolution of acute leukemia genomes.
Jan M; Majeti R
Oncogene; 2013 Jan; 32(2):135-40. PubMed ID: 22349821
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic heterogeneity in acute myeloid leukemia.
Li S; Mason CE; Melnick A
Curr Opin Genet Dev; 2016 Feb; 36():100-6. PubMed ID: 27162099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
